XML 141 R55.htm IDEA: XBRL DOCUMENT v3.20.1

Equity-Accounted Investees (Tables)

12 Months Ended

Dec. 31, 2019

Accounted investees with similar activity to that of the Group

Equity Accounted Investees

Schedule of details of equity accounted investees

				Thousands of				Thousands of
				Euros				Euros
		% ownership		31/12/2019		% ownership		31/12/2018
Interstate Blood Bank, Inc.		100.00	%	—		49.19	%	29,595
Bio Blood Components Inc.		0.00	%	—		48.97	%	38,223
Plasma Biological Services, LLC		0.00	%	—		48.90	%	21,809
Access Biologicals LLC		49.00	%	49,922		49.00	%	47,742
Plasmavita HealthCare		50.00	%	10,368		50.00	%	9,920
				60,290				147,289

Schedule of movement in investments in equity-accounted investees

		Thousands of Euros
		2019
Balance at 1 January		—
Transfer accounted investees with similar activity to that of the Group		147,289
Transfers		(94,127)
Share of profit / (losses)		8,972
Share of other comprehensive income / translation differences		2,624
Losses for Impairment		—
Collected dividends		(4,468)
Balance at 31 December		60,290

Access Biologicals LLC

Equity Accounted Investees

Schedule of movement in investments in equity-accounted investees

		Thousand of Euros
		31/12/2019		31/12/2018
Balance at 1 January		47,742		44,219
Acquisitions		—		—
Share of profit / (losses)		3,938		3,039
Share of other comprehensive income / translation differences		967		2,073
Collected dividends		(2,725)		(1,589)
Balance at 31 December		49,922		47,742

Interstated Blood Bank, Inc. Group

Equity Accounted Investees

Schedule of movement in investments in equity-accounted investees

		Thousands of Euros						Thousands of Euros
		31/12/2019						31/12/2018
		IBBI		Bio-Blood		PBS		IBBI		Bio-Blood		PBS		TOTAL 2019		TOTAL 2018
Balance at 1 January		29,595		38,223		21,809		27,936		32,960		23,010		89,627		83,906
Transfers		(31,453)		(38,606)		(24,068)		—		—		—		(94,127)		—
Share of profit / (losses)		6,853		(2,543)		276		1,830		3,492		(2,181)		4,586		3,141
Share of other comprehensive income / translation differences		(3,251)		2,926		1,983		1,298		1,771		980		1,658		4,049
Collected dividend		(1,744)		—		—		(1,469)		—		—		(1,744)		(1,469)
Balance at 31 December		—		—		—		29,595		38,223		21,809		—		89,627

Rest of equity accounted investees

Equity Accounted Investees

Schedule of details of equity accounted investees

				Thousands of Euros				Thousands of Euros
		% ownership		31/12/2019		% ownership		31/12/2018
Alkahest, Inc.		47.58	%	14,708		47.58	%	28,336
Albajuna Therapeutics, S.L		49.00	%	5,228		30.00	%	1,106
Singulex, Inc.		0.00	%	—		19.33	%	19,256
GigaGen, Inc		43.96	%	23,997		43.96	%	28,363
Mecwins, S.A.		24.99	%	2,338		24.99	%	2,555
Medcom Advance, S.A		45.00	%	7,912		—		—
				54,183				79,616

Schedule of movement in investments in equity-accounted investees

		Thousands of Euros
		2019		2018		2017
Balance at 1 January		79,616		219,009		201,345
Acquisitions		12,369		12,222		80,685
Transfers		—		500		(16,000)
Share of profit / (losses)		(19,744)		(11,038)		(13,195)
Share of other comprehensive income / translation differences		1,736		9,270		(27,134)
Losses for Impairment		(19,794)		—		(6,692)
Collected dividends		—		(3,058)		—
Balance at 31 December		54,183		226,905		219,009

GigaGen, Inc

Equity Accounted Investees

Schedule of movement in investments in equity-accounted investees

		Thousand of Euros
		31/12/2019		31/12/2018
Balance at 1 January		28,363		29,047
Acquisitions		—		—
Share of profit / (losses)		(5,002)		(1,562)
Share of other comprehensive income / translation differences		636		878
Balance at 31 December		23,997		28,363

Singulex, Inc.

Equity Accounted Investees

Schedule of movement in investments in equity-accounted investees

		Thousand of Euros
		31/12/2019		31/12/2018
Balance at 1 January		19,256		29,322
Share of profit / (losses)		—		(10,975)
Share of other comprehensive income / translation differences		538		909
Losses for Impairment		(19,794)		—
Balance at 31 December		—		19,256

X

- Definition

The disclosure of the reconciliation of changes in investments accounted for using the equity method.

+ References

No definition available.

+ Details

Name:	grfs_DisclosureOfReconciliationOfChangesInInvestmentsAccountedForUsingEquityMethodTableTextBlock
Namespace Prefix:	grfs_
Data Type:	nonnum:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

The disclosure of investments accounted for using the equity method. [Refer: Investments accounted for using equity method]

+ References

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Name IAS
-Number 1
-IssueDate 2019-01-01
-Paragraph 10
-Subparagraph e
-URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2019-en-r&anchor=para_10_e&doctype=Standard
-URIDate 2019-03-27

+ Details

Name:	ifrs-full_DisclosureOfInvestmentsAccountedForUsingEquityMethodExplanatory
Namespace Prefix:	ifrs-full_
Data Type:	nonnum:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes of the table.

+ References

No definition available.

+ Details

Name:	ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesLineItems
Namespace Prefix:	ifrs-full_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- Details

Name:	ifrs-full_SignificantInvestmentsInAssociatesAxis=grfs_EquityAccountedInvesteesGroupOneMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	ifrs-full_SignificantInvestmentsInAssociatesAxis=grfs_AccessBiologicalsLLCMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	ifrs-full_SignificantInvestmentsInAssociatesAxis=grfs_InterstatedBloodBankInc.GroupMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	ifrs-full_SignificantInvestmentsInAssociatesAxis=grfs_EquityAccountedInvesteesGroupTwoMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	ifrs-full_SignificantInvestmentsInAssociatesAxis=grfs_GigagenIncMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	ifrs-full_SignificantInvestmentsInAssociatesAxis=grfs_SingulexIncorporatedMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type: